217 related articles for article (PubMed ID: 5371307)
21. [Insulin secretion as studied on isolated perfused rat pancreas. I. Synergism between glucose and hypoglycaemic sulphonamides].
Loubatières A; Mariani MM; Chapal J
Diabetologia; 1970 Oct; 6(5):457-66. PubMed ID: 4919967
[No Abstract] [Full Text] [Related]
22. Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper- and hypoglycemic sulfonamides.
Samols E; Weir GC; Ramseur R; Day JA; Patel YC
Metabolism; 1978 Sep; 27(9 Suppl 1):1219-21. PubMed ID: 682983
[No Abstract] [Full Text] [Related]
23. Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas.
Bosboom RS; Zweens J; Bouman PR
Diabetologia; 1973 Aug; 9(4):243-50. PubMed ID: 4203349
[No Abstract] [Full Text] [Related]
24. [Interaction between tolbutamide and theophylline, as studied on insulin secretion by the isolated, perfused rat pancreas].
Loubatières AL; Loubatières-Mariani MM; Chapal J
C R Seances Soc Biol Fil; 1973; 167(12):1892-5. PubMed ID: 4802802
[No Abstract] [Full Text] [Related]
25. Primary secretion of insulin and secondary release of glucagon from the isolated perfused rat pancreas following stimulation with pancreozymin.
Fussgänger RD; Straub K; Goberna R; Jaros P; Schröder KE; Raptis S; Pfeiffer EF
Horm Metab Res; 1969 Jul; 1(4):224-7. PubMed ID: 5407085
[No Abstract] [Full Text] [Related]
26. Tissue distribution and metabolism of drugs VI: Effect of second drugs on pancreatic distribution and insulin-releasing activity of sulfonylureas in perfused rat pancreas.
Okumura K; Arakawa M; Hori R
J Pharm Sci; 1980 Feb; 69(2):157-9. PubMed ID: 6987371
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
28. Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
Ledercq-Meyer V; Akkan AG; Marchand J; Malaisse WJ
Biochem Pharmacol; 1991 Sep; 42(8):1634-7. PubMed ID: 1930290
[TBL] [Abstract][Full Text] [Related]
29. Effect of glipizide on the release of insulin in the perfused rat pancreas in vitro.
Tasaka Y; Sekine M; Sugimoto C; Ogawara H; Shizume K
Endocrinol Jpn; 1974 Jun; 21(3):279-81. PubMed ID: 4426313
[No Abstract] [Full Text] [Related]
30. [Quantitative pharmacodynamics with an endocrine cell: sulfonylureas and insulin secretion].
Alric R; Portal A
Therapie; 1969; 24(5):871-80. PubMed ID: 5364207
[No Abstract] [Full Text] [Related]
31. The in vitro perfused pancreas.
Grodsky GM; Fanska RE
Methods Enzymol; 1975; 39():364-72. PubMed ID: 1097860
[No Abstract] [Full Text] [Related]
32. [Oral antidiabetics. Dose, plasma concentration and effect].
Ariëns EJ
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():143-76. PubMed ID: 4392071
[No Abstract] [Full Text] [Related]
33. Tungstate stimulates insulin release and inhibits somatostatin output in the perfused rat pancreas.
Silvestre RA; Egido EM; Hernández R; Marco J
Eur J Pharmacol; 2005 Sep; 519(1-2):127-34. PubMed ID: 16126195
[TBL] [Abstract][Full Text] [Related]
34. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine.
Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M
Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038
[TBL] [Abstract][Full Text] [Related]
35. Fructose potentiation of insulin secretion.
Curry DL; Curry KP; Gomez M
Endocrinology; 1972 Dec; 91(6):1493-8. PubMed ID: 5086141
[No Abstract] [Full Text] [Related]
36. Glucagon is paradoxically secreted at high concentrations of glucose in rat pancreas perfused with diazoxide.
Mokuda O; Shibata M; Ooka H; Okazaki R; Sakamoto Y
Diabetes Nutr Metab; 2002 Aug; 15(4):260-4. PubMed ID: 12416665
[TBL] [Abstract][Full Text] [Related]
37. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
[No Abstract] [Full Text] [Related]
38. [Insulin liberation from the pancreas by sulfonylurea].
Pfaff W; Schöne HH
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1445-8. PubMed ID: 4899084
[No Abstract] [Full Text] [Related]
39. Ay-4166 increases the sensitivity of insulin secretion to glucose in isolated perfused rat pancreas.
Morimoto S; Mokuda O; Sakamoto Y
Horm Metab Res; 1998 Feb; 30(2):77-9. PubMed ID: 9543688
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
